[go: up one dir, main page]

TR199701497T1 - Beyin ödemini önleyen terkip. - Google Patents

Beyin ödemini önleyen terkip.

Info

Publication number
TR199701497T1
TR199701497T1 TR97/01497T TR9701497T TR199701497T1 TR 199701497 T1 TR199701497 T1 TR 199701497T1 TR 97/01497 T TR97/01497 T TR 97/01497T TR 9701497 T TR9701497 T TR 9701497T TR 199701497 T1 TR199701497 T1 TR 199701497T1
Authority
TR
Turkey
Prior art keywords
endothelin antagonist
treating
brain edemas
edemas
composition
Prior art date
Application number
TR97/01497T
Other languages
English (en)
Inventor
Ninomiya Mitsuyoshi
Matsuo Yoshiyuki
Original Assignee
Shionogi & Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co., Ltd. filed Critical Shionogi & Co., Ltd.
Publication of TR199701497T1 publication Critical patent/TR199701497T1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Bu bulus, beyin ödemlerinin tedavisi- veya önlenmesi için, aktif bir madde olarak bir endotelin antagonist içeren bir terkip ile örnegin, asagidaki formül (I) bilesimi; veya onun farmasötik olarak kabul edilebilir tuzlari veya hidratlari; bosentan, sislo
TR97/01497T 1995-06-02 1996-05-29 Beyin ödemini önleyen terkip. TR199701497T1 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16006095 1995-06-02

Publications (1)

Publication Number Publication Date
TR199701497T1 true TR199701497T1 (tr) 1998-06-22

Family

ID=15707042

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/01497T TR199701497T1 (tr) 1995-06-02 1996-05-29 Beyin ödemini önleyen terkip.

Country Status (16)

Country Link
US (1) US5945448A (tr)
EP (1) EP0838223B1 (tr)
JP (1) JP4011114B2 (tr)
KR (1) KR100399797B1 (tr)
CN (1) CN1083261C (tr)
AT (1) ATE245447T1 (tr)
AU (1) AU700182B2 (tr)
BR (1) BR9608413A (tr)
CA (1) CA2218028C (tr)
DE (1) DE69629195T2 (tr)
DK (1) DK0838223T3 (tr)
ES (1) ES2202449T3 (tr)
PT (1) PT838223E (tr)
TR (1) TR199701497T1 (tr)
TW (1) TW460286B (tr)
WO (1) WO1996038173A1 (tr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482857B1 (en) 1998-07-17 2002-11-19 The University Of Texas Southwestern Medical Center Compositions which contain triterpenes for regulating hair growth
US6124362A (en) 1998-07-17 2000-09-26 The Procter & Gamble Company Method for regulating hair growth
TWI232102B (en) * 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
JP2007217438A (ja) * 2001-07-17 2007-08-30 Shionogi & Co Ltd 注射用医薬製剤
US20040138187A1 (en) 2002-08-28 2004-07-15 Reading Christopher L. Therapeutic treatment methods
WO2006098800A1 (en) 2005-01-14 2006-09-21 Airlite Plastics Co. Insulated foam panel forms
RU2008136317A (ru) * 2006-03-13 2010-04-20 Инсайсив Фармасьютикалз, Инк. (US) Способы и композиции для лечения диагностикой сердечной недостаточности
US8071596B2 (en) 2007-01-12 2011-12-06 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
US8080549B2 (en) 2007-01-12 2011-12-20 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
CA2793668A1 (en) 2011-10-31 2013-04-30 Bradley J. Crosby An apparatus and method for construction of structures utilizing insulated concrete forms
CA2801735C (en) 2012-01-13 2019-08-06 Bradley J. Crosby An apparatus and method for construction of structures utilizing insulated concrete forms
USD713975S1 (en) 2012-07-30 2014-09-23 Airlite Plastics Co. Insulative insert for insulated concrete form
US10787827B2 (en) 2016-11-14 2020-09-29 Airlite Plastics Co. Concrete form with removable sidewall
CA3061942A1 (en) 2018-11-19 2020-05-19 Bradley J. Crosby Concrete form with removable sidewall

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012991A1 (fr) * 1991-01-29 1992-08-06 Shionogi Seiyaku Kabushiki Kaisha Derive de triterpene
TW272974B (tr) * 1993-06-11 1996-03-21 Shionogi & Co
US5599811A (en) * 1995-02-21 1997-02-04 Warner-Lambert Company Benzothiazine dioxides as endothelin antagonists

Also Published As

Publication number Publication date
DE69629195D1 (de) 2003-08-28
BR9608413A (pt) 1998-12-29
KR100399797B1 (ko) 2004-04-13
CN1083261C (zh) 2002-04-24
ATE245447T1 (de) 2003-08-15
US5945448A (en) 1999-08-31
AU700182B2 (en) 1998-12-24
ES2202449T3 (es) 2004-04-01
PT838223E (pt) 2003-12-31
DK0838223T3 (da) 2003-11-17
DE69629195T2 (de) 2004-05-06
CA2218028C (en) 2010-07-06
CN1186441A (zh) 1998-07-01
TW460286B (en) 2001-10-21
AU5844096A (en) 1996-12-18
WO1996038173A1 (en) 1996-12-05
KR19990008341A (ko) 1999-01-25
CA2218028A1 (en) 1996-12-05
MX9708920A (es) 1998-03-31
EP0838223A1 (en) 1998-04-29
EP0838223B1 (en) 2003-07-23
JP4011114B2 (ja) 2007-11-21
EP0838223A4 (en) 2001-04-25

Similar Documents

Publication Publication Date Title
ATE195117T1 (de) 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren
TR199701497T1 (tr) Beyin ödemini önleyen terkip.
ES2295609T3 (es) Derivados de tiadiazolilpiperazina utiles para tratar o prevenir un dolor.
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
RU94044454A (ru) Ингибитор аутоимунных заболеваний
WO1992019211A3 (en) Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
RU94044356A (ru) Применение 2-фенил-3-ароилбензотиофенов для увеличения экспрессии тромбомодулина для ингибирования тромботического расстройства, для увеличения активации протеина с
AU2101492A (en) Methanoanthracenes having antidopaminergic activity
DE69315699D1 (de) Inhibitoren gegen die aggregation von blutplättchen
RU98101105A (ru) Новое применение в медицинских целях
DE60225143D1 (de) Synergistische pharmazeutische zusammensetzungen zur behandlung bzw. prophylaxe von diabetes
RU94045271A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
ATE160143T1 (de) 2-substituierte morpholin- und thiomorpholinderivate als gaba-b antagonisten
KR950032194A (ko) 신규푸린유도체 및 그 약학적으로 허용되는 염
ATE159511T1 (de) Derivate von n,n,n',n'-tetrasubstituierten 1,2- ethylendiamin-verbindungen
ES2144452T3 (es) Medicamento para el tratamiento de infecciones protozoarias provocadas por babesia.
NO993911L (no) Remedier/Forebygningsmidler for Õndedrettssykdommer
MY133957A (en) "compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor"
DK0674645T3 (da) Cephemforbindelser med antimikrobiel virkning